Edward P. Feener - 17 May 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Reporting relationship: CHIEF SCIENTIFIC OFFICER
Issuer ticker: KALV
Reported as of: 17 May 2024
Net transaction value: -$95,151
SEC form: 4
Accepted by SEC: 21 May 2024, 17:59:02 UTC
Prior SEC filing: 21 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact

Key filing fact

Edward P. Feener filed Form 4 for KalVista Pharmaceuticals, Inc. (KALV) on 21 May 2024.

Key facts

This page summarizes Edward P. Feener's Form 4 filing for KalVista Pharmaceuticals, Inc. (KALV).
6 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 21 May 2024, 17:59.

Change

Previous filing in this sequence was filed on 21 Feb 2024.
Current net transaction value: -$95,151.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KALV transaction

Common Stock

Options Exercise

Transaction value
Shares: +18,789
Change %: +30%
Price
Shares after: 80,946
Date: 17 May 2024
Ownership: Direct
Footnotes: F1

KALV transaction

Common Stock

Sale

Transaction value: $95,151
Shares: -8,088
Change %: -10%
Price: $11.76
Shares after: 72,858
Date: 20 May 2024
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KALV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -1,774
Change %: -11%
Price: $0.000000
Shares after: 14,190
Date: 17 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,774
Exercise price
Footnotes: F1, F4

KALV transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -2,431
Change %: -14%
Price: $0.000000
Shares after: 14,583
Date: 17 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,431
Exercise price
Footnotes: F1, F5

KALV transaction Derivative

Performance Stock Units

Options Exercise

Transaction value: $0
Shares: -7,292
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 17 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,292
Exercise price
Footnotes: F1, F6

KALV transaction Derivative

Performance Stock Units

Options Exercise

Transaction value: $0
Shares: -7,292
Change %: -33%
Price: $0.000000
Shares after: 14,583
Date: 17 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,292
Exercise price
Footnotes: F1, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Footnote F2

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs and PSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.7644 to $11.965 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on August 17, 2022, subject to continued service through each vesting date.

Footnote F5

1/12th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on November 17, 2022, subject to continued service through each vesting date.

Footnote F6

Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on June 8, 2023. Each PSU represents a contingent right to receive one share of Issuer Common Stock upon the Issuer's achievement of performance metric goals ("Performance Metrics"). 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of August 17, 2023, upon Performance Metrics achieved, subject to continued service through each vesting date.

Footnote F7

Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on January 10, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of Performance Metrics. 1/4th of the total number of shares subject to the PSU shall vest on each quarterly anniversary of the Vesting Commencement Date of February 17, 2024, upon Performance Metrics achieved, subject to continued service through each vesting date.